Hematologic analysis of hospitalized patients and outpatients infected with SARS-CoV-2 and possible use as a prognostic biomarker

•Outpatients do not experience changes in erythroid series.•Hematic biometry can be used as a biomarker of the severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).•Increases in neutrophil and decreases in lymphocyte counts suggest a prognosis of the severity of the disease. Seve...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Experimental hematology 2023-03, Vol.119-120, p.21-27
Hauptverfasser:	Girón-Pérez, Daniel Alberto, Nava-Piedra, Ulises Netzahualcoyotl, Esquivel-Esparza, Zulema Estefania, Benitez-Trinidad, Alma Betsaida, Barcelos-Garcia, Rocio Guadalupe, Vázquez-Pulido, Erica Yolanda, Toledo-Ibarra, Gladys Alejandra, Ventura-Ramón, Guadalupe Herminia, Covantes-Rosales, Carlos Eduardo, Barajas-Carrillo, Victor Wagner, Ojeda-Durán, Ansonny Jhovanny, Díaz-Resendiz, Karina Janice Guadalupe, Mercado-Salgado, Ulises, Girón-Pérez, Manuel Iván
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 Female Hospitalization Humans Male Middle Aged Outpatients Prognosis SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!